Boston Scientific Corporation: Aortic Valve Stenosis trials

The registry lists 30 Aortic Valve Stenosis studies with Boston Scientific Corporation as lead sponsor. 0 are open to participants now and 7 have results posted.

No phase 30(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve ReplacementActive, not recruitingNCT03735667Not applicableResults posted
• REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk SubjectsTerminatedNCT03618095Not applicableResults posted
• Self-Centering Guide Catheter Feasibility StudyCompletedNCT02639494Not applicableResults posted
• Cerebral Protection in Transcatheter Aortic Valve ReplacementCompletedNCT02214277Not applicableResults posted
• Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve ReplacementTerminatedNCT02202434Not applicableResults posted
• RESPOND Post Market StudyCompletedNCT02031302Results posted
• REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEmCompletedNCT01383720Not applicableResults posted
• ACURATE Enhance Post Market StudyWithdrawnNCT06959862
• ACURATE Prime XL Human Feasibility StudyCompletedNCT05224245Not applicable
• ACURATE neo2™ Post Market Clinical Follow up StudyActive, not recruitingNCT04655248
• RESPOND EDGE Post Market StudyTerminatedNCT04009720
• ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)CompletedNCT03752996Not applicable
• Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01)CompletedNCT03567278Not applicable
• CHANGE Neo™ TA Registry With ACURATE Neo™ Aortic Bioprosthesis and ACURATE Neo™ TA Transapical Delivery SystemTerminatedNCT03454360
• ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)CompletedNCT03143686
• ACURATE™ Transapical Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2010-01)CompletedNCT03143673Not applicable
• REPRISE China - Clinical Evaluation in ChinaWithdrawnNCT03084510Not applicable
• Performance and Safety of the Lotus™ Valve With a FLEXible Delivery SystemCompletedNCT03043404Not applicable
• ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval CohortCompletedNCT03003650Not applicable
• PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL RegistryCompletedNCT02987894
• ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic StenosisCompletedNCT02986737Not applicable
• REPRISE EDGE 29 mm EU StudyWithdrawnNCT02964962Not applicable
• ACURATE Neo™ TA Delivery System in Patient With Severe Aortic StenosisCompletedNCT02950428Not applicable
• ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic StenosisCompletedNCT02909556Not applicable
• REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve SystemTerminatedNCT02854319Not applicable
• ACURATE TA™ Valve Implantation Registry: SAVI 2CompletedNCT02663375
• Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)CompletedNCT02491255Not applicable
• REPRISE Next Generation Delivery SystemCompletedNCT02329496Not applicable
• Symetis ACURATE Neo™ Valve Implantation SAVI TF RegistryCompletedNCT02306226
• Sentinel(TM) Post-Market RegistryCompletedNCT02255851